Literature DB >> 22875758

Clinical utility in evaluation of risk models.

Sholom Wacholder.   

Abstract

Mesh：

Year:  2012        PMID： 22875758      PMCID： PMC3491966          DOI： 10.1093/aje/kws255

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN： 0002-9262            Impact factor:   4.897


× No keyword cloud information.
  7 in total

1.  Pencina et al. respond to "The incremental value of new markers" and "Clinically relevant measures? A note of caution".

Authors:  Michael J Pencina; Ralph B D'Agostino; Olga V Demler; A Cecile J W Janssens; Philip Greenland
Journal:  Am J Epidemiol       Date:  2012-08-08       Impact factor: 4.897

2.  Further insight into the incremental value of new markers: the interpretation of performance measures and the importance of clinical context.

Authors:  Kathleen F Kerr; Aasthaa Bansal; Margaret S Pepe
Journal:  Am J Epidemiol       Date:  2012-08-08       Impact factor: 4.897

3.  Interpreting incremental value of markers added to risk prediction models.

Authors:  Michael J Pencina; Ralph B D'Agostino; Karol M Pencina; A Cecile J W Janssens; Philip Greenland
Journal:  Am J Epidemiol       Date:  2012-08-08       Impact factor: 4.897

4.  Clinically relevant measures of fit? A note of caution.

Authors:  Nancy R Cook
Journal:  Am J Epidemiol       Date:  2012-08-08       Impact factor: 4.897

5.  Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice.

Authors:  Hormuzd A Katki; Walter K Kinney; Barbara Fetterman; Thomas Lorey; Nancy E Poitras; Li Cheung; Franklin Demuth; Mark Schiffman; Sholom Wacholder; Philip E Castle
Journal:  Lancet Oncol       Date:  2011-06-16       Impact factor: 41.316

6.  Risk estimation for the next generation of prevention programmes for cervical cancer.

Authors:  Hormuzd A Katki; Sholom Wacholder; Diane Solomon; Philip E Castle; Mark Schiffman
Journal:  Lancet Oncol       Date:  2009-09-18       Impact factor: 41.316

7.  Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association.

Authors:  Mark A Hlatky; Philip Greenland; Donna K Arnett; Christie M Ballantyne; Michael H Criqui; Mitchell S V Elkind; Alan S Go; Frank E Harrell; Yuling Hong; Barbara V Howard; Virginia J Howard; Priscilla Y Hsue; Christopher M Kramer; Joseph P McConnell; Sharon-Lise T Normand; Christopher J O'Donnell; Sidney C Smith; Peter W F Wilson
Journal:  Circulation       Date:  2009-04-13       Impact factor: 29.690
  7 in total
  4 in total

Review 1.  Prediction of treatment outcomes in psychiatry--where do we stand ?

Authors:  Francis J McMahon
Journal:  Dialogues Clin Neurosci       Date:  2014-12       Impact factor: 5.986

2.  Adipocytokines, hepatic and inflammatory biomarkers and incidence of type 2 diabetes. the CoLaus study.

Authors:  Pedro Marques-Vidal; Rémy Schmid; Murielle Bochud; François Bastardot; Roland von Känel; Fred Paccaud; Jennifer Glaus; Martin Preisig; Gérard Waeber; Peter Vollenweider
Journal:  PLoS One       Date:  2012-12-12       Impact factor: 3.240

3.  Replication and predictive value of SNPs associated with melanoma and pigmentation traits in a Southern European case-control study.

Authors:  Irene Stefanaki; Orestis A Panagiotou; Elisavet Kodela; Helen Gogas; Katerina P Kypreou; Foteini Chatzinasiou; Vasiliki Nikolaou; Michaela Plaka; Iro Kalfa; Christina Antoniou; John P A Ioannidis; Evangelos Evangelou; Alexander J Stratigos
Journal:  PLoS One       Date:  2013-02-05       Impact factor: 3.240

4.  Measuring Burden of Unhealthy Behaviours Using a Multivariable Predictive Approach: Life Expectancy Lost in Canada Attributable to Smoking, Alcohol, Physical Inactivity, and Diet.

Authors:  Douglas G Manuel; Richard Perez; Claudia Sanmartin; Monica Taljaard; Deirdre Hennessy; Kumanan Wilson; Peter Tanuseputro; Heather Manson; Carol Bennett; Meltem Tuna; Stacey Fisher; Laura C Rosella
Journal:  PLoS Med       Date:  2016-08-16       Impact factor: 11.069
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.